Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04269304
What this trial is testing

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE

Who this might be right for
Age-related Macular Degeneration
University of Southampton 429
Not applicableLooking for participantsNCT05959005
What this trial is testing

Progression of Early Atrophic Lesions

Who this might be right for
Age-Related Macular Degeneration
University of Utah 125
Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Not applicableStudy completedNCT02762188
What this trial is testing

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Who this might be right for
Age-Related Macular Degeneration
Brugmann University Hospital 501
Not applicableStudy completedNCT05281042
What this trial is testing

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 20
Large-scale testing (Phase 3)UnknownNCT00000161
What this trial is testing

Randomized Trials of Vitamin Supplements and Eye Disease

Who this might be right for
Macular DegenerationCataract
National Eye Institute (NEI)
Testing effectiveness (Phase 2)Study completedNCT04656561
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Annexon, Inc. 270
Testing effectiveness (Phase 2)Ended earlyNCT01021956
What this trial is testing

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Steba Biotech S.A. 10
Not applicableStudy completedNCT03242083
What this trial is testing

Evaluate the Quality of Life of Patients With AMD

Who this might be right for
Age-related Macular Degeneration
Centre Hospitalier Universitaire Dijon 28
Testing effectiveness (Phase 2)Study completedNCT00612456
What this trial is testing

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Who this might be right for
Macular Degeneration
GlaxoSmithKline 70
Not applicableStudy completedNCT06213896
What this trial is testing

Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images

Who this might be right for
GlaucomaAge-Related Macular DegenerationRetinal Vein Occlusion+3 more
Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi 1,528
Post-approval studies (Phase 4)Study completedNCT03169660
What this trial is testing

Intravitreal Aflibercept for Submacular Hemorrhage

Who this might be right for
Exudative Age-related Macular Degeneration
Kim's Eye Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05390840
What this trial is testing

Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Theratocular Biotek Co. 36
Not applicableStudy completedNCT05678517
What this trial is testing

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Semmelweis University 47
Not applicableUnknownNCT02747368
What this trial is testing

Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Turku University Hospital 600
Large-scale testing (Phase 3)Study completedNCT03844074
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT00712491
What this trial is testing

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Santen Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT00695318
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
Alimera Sciences 17
Very early researchStudy completedNCT00517010
What this trial is testing

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
University of California, Davis 6
Testing effectiveness (Phase 2)Looking for participantsNCT07606365
What this trial is testing

A Study in Adults With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Sitala Bio LTD 300
Next Page